Related references
Note: Only part of the references are listed.Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease A Truncated Randomized Phase 2b/3 Clinical Trial
Reisa Sperling et al.
JAMA NEUROLOGY (2021)
Synthesis of the Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor NB-360
Heinrich Rueeger et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
The case for low-level BACE1 inhibition for the prevention of Alzheimer disease
Eric McDade et al.
NATURE REVIEWS NEUROLOGY (2021)
Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2
Liping H. Pettus et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials
Alette M. Wessels et al.
JAMA NEUROLOGY (2020)
A Pooled Analysis of Three Randomized Phase I/IIa Clinical Trials Confirms Absence of a Clinically Relevant Effect on the QTc Interval by Umibecestat
Stefan Viktor Vormfelde et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)
Investigational BACE inhibitors for the treatment of Alzheimer's disease
Bruno P. Imbimbo et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)
Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015-2060) in adults aged >= 65 years
Kevin A. Matthews et al.
ALZHEIMERS & DEMENTIA (2019)
Discovery of amino-1,4-oxazines as potent BACE-1 inhibitors
Siem Jakob Veenstra et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Impact of Dynamically Exposed Polarity on Permeability and Solubility of Chameleonic Drugs Beyond the Rule of 5
Matteo Rossi Sebastiano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Design and Synthesis of Clinical Candidate PF-06751979: A Potent, Brain Penetrant, β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor Lacking Hypopigmentation
Brian T. O'Neill et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease
Ulf Neumann et al.
EMBO MOLECULAR MEDICINE (2018)
Axonal organization defects in the hippocampus of adult conditional BACE1 knockout mice
Ming-Hsuan Ou-Yang et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients
Matthew E. Kennedy et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
BACE1 Physiolocical Functions May Limit Its Use as Therapeutic Tarcet for Alzneimer's Disease
Soraia Barao et al.
TRENDS IN NEUROSCIENCES (2016)
Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice
Derya R. Shimshek et al.
SCIENTIFIC REPORTS (2016)
Pharmacological Inhibition of BACE1 Impairs Synaptic Plasticity and Cognitive Functions
Severin Filser et al.
BIOLOGICAL PSYCHIATRY (2015)
Current Thinking on the Mechanistic Basis of Alzheimer's and Implications for Drug Development
C. Ising et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice
Ulf Neumann et al.
MOLECULAR NEURODEGENERATION (2015)
The A4 Study: Stopping AD Before Symptoms Begin?
Reisa A. Sperling et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer's Disease
Hans Hilpert et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Structure-Based Design of β-Site APP Cleaving Enzyme 1 (BACE1) Inhibitors for the Treatment of Alzheimer's Disease
Jing Yuan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells
Leila Rochin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Structural Modifications that Alter the P-Glycoprotein Efflux Properties of Compounds
Stephen A. Hitchcock
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Biochemistry of Amyloid β-Protein and Amyloid Deposits in Alzheimer Disease
Colin L. Masters et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Trafficking and Proteolytic Processing of APP
Christian Haass et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Structure based design, synthesis and SAR of cyclic hydroxyethylamine (HEA) BACE-1 inhibitors
Heinrich Rueeger et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Enantioselective Silylcyanation of Aldehydes and Ketones by a Titanium Catalyst Prepared from a Partially Hydrolyzed Titanium Alkoxide and a Schiff Base Ligand
Kazuhiko Yoshinaga et al.
ADVANCED SYNTHESIS & CATALYSIS (2009)
A facile method for the synthesis of substituted pyrazolo[3,4-c]pyridines
Sharad K. Verma et al.
TETRAHEDRON LETTERS (2009)
Ligand structural aspects of hERG channel blockade
Alex M. Aronov
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2008)
In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system
Bo Feng et al.
DRUG METABOLISM AND DISPOSITION (2008)
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery
Hong Wan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Crystal structure of human BACE2 in complex with a hydroxyethylamine transition-state inhibitor
N Ostermann et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Structure-based design, synthesis, and memapsin 2 (BACE) inhibitory activity of carbocyclic and heterocyclic peptidomimetics
S Hanessian et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier
Q Wang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
APRV -: a program for automated data processing, refinement and visualization
M Kroemer et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2004)
Apo and inhibitor complex structures of BACE (β-secretase)
S Patel et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Classification analysis of P-glycoprotein substrate specificity
R Didziapetris et al.
JOURNAL OF DRUG TARGETING (2003)
High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes
F Wohnsland et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Share Paper
